ANI PHARMACEUTICALS, INC Operating Leases, Rent Expense
ANI PHARMACEUTICALS, INC (ANIP) reported Operating Leases, Rent Expense of $81.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2017-03-02
- ANI PHARMACEUTICALS, INC operating leases, rent expense for the quarter ending 2016-12-31 was $20.00K, a 17.65% increase year-over-year.
- ANI PHARMACEUTICALS, INC operating leases, rent expense for the quarter ending 2016-09-30 was $22.00K, a 15.79% increase year-over-year.
- ANI PHARMACEUTICALS, INC operating leases, rent expense for the quarter ending 2016-06-30 was $20.00K, a 0.00% change year-over-year.
- ANI PHARMACEUTICALS, INC operating leases, rent expense for the quarter ending 2016-03-31 was $19.00K, a 5.56% increase year-over-year.
- ANI PHARMACEUTICALS, INC operating leases, rent expense for fiscal 2016 was $81.00K, a 9.46% increase from fiscal 2015.
- ANI PHARMACEUTICALS, INC operating leases, rent expense for fiscal 2015 was $74.00K, a 5.71% increase from fiscal 2014.
- ANI PHARMACEUTICALS, INC operating leases, rent expense for fiscal 2014 was $70.00K, a 94.44% increase from fiscal 2013.
- ANI PHARMACEUTICALS, INC operating leases, rent expense for fiscal 2013 was $36.00K, a 100.00% increase from fiscal 2012.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 3 month as first filed | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 6 month as first filed | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 9 month as first filed | Operating Leases, Rent Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2016-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $42.00K derived: sum of 2 quarters · filed 2017-03-02 | $62.00K derived: sum of 3 quarters · filed 2017-03-02 | $81.00K 10-K · filed 2017-03-02 | |||
| 2016-09-30 | $22.00K 10-Q · filed 2016-11-03 | $42.00K derived: sum of 2 quarters · filed 2016-11-03 | $61.00K 10-Q · filed 2016-11-03 | $78.00K derived: sum of 4 quarters · filed 2017-03-02 | |||
| 2016-06-30 | $20.00K 10-Q · filed 2016-08-04 | $40.00K 10-Q · filed 2016-08-04 | $56.00K derived: sum of 3 quarters · filed 2017-03-02 | $75.00K derived: sum of 4 quarters · filed 2017-03-02 | |||
| 2016-03-31 | $19.00K 10-Q · filed 2016-05-05 | $36.00K derived: sum of 2 quarters · filed 2017-03-02 | $55.00K derived: sum of 3 quarters · filed 2017-03-02 | $75.00K derived: sum of 4 quarters · filed 2017-03-02 | |||
| 2015-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $36.00K derived: sum of 2 quarters · filed 2017-03-02 | $56.00K derived: sum of 3 quarters · filed 2017-03-02 | $74.00K 10-K · filed 2017-03-02 | |||
| 2015-09-30 | $19.00K 10-Q · filed 2016-11-03 | $39.00K derived: sum of 2 quarters · filed 2016-11-03 | $57.00K 10-Q · filed 2016-11-03 | $74.00K derived: sum of 4 quarters · filed 2017-03-02 | |||
| 2015-06-30 | $20.00K 10-Q · filed 2016-08-04 | $38.00K 10-Q · filed 2016-08-04 | $55.00K derived: sum of 3 quarters · filed 2017-03-02 | $72.00K derived: sum of 4 quarters · filed 2017-03-02 | |||
| 2015-03-31 | $18.00K 10-Q · filed 2016-05-05 | $35.00K derived: sum of 2 quarters · filed 2017-03-02 | $52.00K derived: sum of 3 quarters · filed 2017-03-02 | $71.00K derived: sum of 4 quarters · filed 2017-03-02 | |||
| 2014-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $34.00K derived: sum of 2 quarters · filed 2017-03-02 | $53.00K derived: sum of 3 quarters · filed 2017-03-02 | $70.00K 10-K · filed 2017-03-02 | |||
| 2014-09-30 | $17.00K 10-Q · filed 2015-11-03 | $36.00K derived: sum of 2 quarters · filed 2015-11-03 | $53.00K 10-Q · filed 2015-11-03 | $63.00K derived: sum of 4 quarters · filed 2016-02-23 | |||
| 2014-06-30 | $19.00K 10-Q · filed 2015-08-04 | $36.00K 10-Q · filed 2015-08-04 | $46.00K derived: sum of 3 quarters · filed 2016-02-23 | $57.00K derived: sum of 4 quarters · filed 2016-02-23 | |||
| 2014-03-31 | $17.00K 10-Q · filed 2015-05-05 | $27.00K derived: sum of 2 quarters · filed 2016-02-23 | $38.00K derived: sum of 3 quarters · filed 2016-02-23 | $48.00K derived: sum of 4 quarters · filed 2016-02-23 | |||
| 2013-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $21.00K derived: sum of 2 quarters · filed 2016-02-23 | $31.00K derived: sum of 3 quarters · filed 2016-02-23 | $36.00K 10-K · filed 2016-02-23 | |||
| 2013-09-30 | $11.00K 10-Q · filed 2014-11-10 | $11.32K 10-Q · filed 2013-11-07 | $21.00K derived: sum of 2 quarters · filed 2014-11-10 | $26.00K 10-Q · filed 2014-11-10 | $25.72K 10-Q · filed 2013-11-07 | $37.01K derived: sum of 4 quarters · filed 2014-11-10 | |
| 2013-06-30 | $10.00K 10-Q · filed 2014-08-07 | $10.27K 10-Q · filed 2013-08-09 | $14.00K 10-Q · filed 2014-08-07 | $14.40K 10-Q · filed 2013-08-09 | $26.01K derived: sum of 3 quarters · filed 2014-08-07 | $28.37K derived: sum of 4 quarters · filed 2014-08-07 | |
| 2013-03-31 | $5.00K 10-Q · filed 2014-05-12 | $16.01K derived: sum of 2 quarters · filed 2014-05-12 | $18.37K derived: sum of 3 quarters · filed 2014-05-12 | $20.76K derived: sum of 4 quarters · filed 2014-05-12 | |||
| 2012-12-31 | $11.01K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $13.37K derived: sum of 2 quarters · filed 2014-02-28 | $15.76K derived: sum of 3 quarters · filed 2014-02-28 | $18.00K 10-K · filed 2014-02-28 | |||
| 2012-09-30 | $2.36K 10-Q · filed 2013-11-07 | $4.75K derived: sum of 2 quarters · filed 2013-11-07 | $6.99K 10-Q · filed 2013-11-07 | ||||
| 2012-06-30 | $2.39K 10-Q · filed 2013-08-09 | $4.63K 10-Q · filed 2013-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |